Product Information:

SALBO HFA 100 MDI is a pressurized metered-dose inhaler (pMDI) containing Salbutamol (Albuterol) 100 mcg per actuation, delivered via a hydrofluoroalkane (HFA) propellant. Salbutamol is a short-acting beta₂-adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm in reversible obstructive airway diseases.

This formulation is used as a rescue (reliever) inhaler for acute symptoms and is environmentally friendly (CFC-free).

Uses of (SALBO HFA 100 MDI):

1. Rapid relief of acute bronchospasm in asthma and chronic obstructive pulmonary disease (COPD)
2. Prevention of exercise-induced bronchospasm (EIB)
3. Symptomatic management of wheezing, shortness of breath, chest tightness, and coughing

Key Benefits of (SALBO HFA 100 MDI):

1. Fast-acting: Onset within 3–5 minutes, peak effect in 30–60 minutes
2. Portable and easy to use with dose counter (if available)
3. HFA propellant: Non-ozone depleting, eco-friendly
4. Reliable rescue therapy during asthma attacks or flare-ups

How To Use (SALBO HFA 100 MDI):

1. Shake well before each use.
2. Prime before first use or if unused for >7 days (spray 4 test doses into the air).
3. Inhale technique:
4. Exhale fully (away from inhaler)
5. Place mouthpiece in mouth, seal lips
6. Press canister while inhaling deeply and slowly
7. Hold breath for 10 seconds, then exhale
8. Dosage:
9. Acute relief: 1–2 puffs every 4–6 hours as needed
10. Exercise-induced bronchospasm: 2 puffs 15–30 minutes before activity
11. Maximum: Do not exceed 8 puffs in 24 hours without medical advice.

⚠️ If >2 days/week are needed for symptom control, asthma is not well-controlled—consult your doctor.

When Not to Use (SALBO HFA 100 MDI):

Do not use if you have:

1. Hypersensitivity to salbutamol or any excipients
2. Tachyarrhythmias or severe cardiac ischemia
3. Paradoxical bronchospasm (worsening after use)—discontinue immediately

Side Effects of (SALBO HFA 100 MDI):

Common: Tremor (especially hands), headache, palpitations, nervousness, throat irritation.

Less common: Muscle cramps, insomnia, hypokalemia (with high doses).

Serious (rare):

1. Paradoxical bronchospasm (wheezing worsens—stop use)
2. Cardiac arrhythmias (in overdose or susceptible individuals)
3. Hypersensitivity reactions (angioedema, urticaria)
4. Seek emergency help if breathing worsens after use or chest pain occurs.

Dosage: (SALBO HFA 100 MDI):

1. Adults & children ≥4 years: 1–2 puffs every 4–6 hours
2. Maximum single dose: 4 puffs (during acute attack under supervision)
3. Not for long-term control—use only as rescue

Who It’s For (SALBO HFA 100 MDI):

1. Asthma patients (≥4 years) requiring quick-relief medication
2. COPD patients with acute bronchospasm
3. Individuals with exercise-induced bronchoconstriction

Warnings & Precautions:

1. Not a controller inhaler—must be used with maintenance therapy (e.g., ICS) if prescribed
2. Overuse (>2 days/week for symptom relief) indicates poor asthma control
3. Use caution in patients with hypertension, hyperthyroidism, diabetes, or seizure disorders
4. May cause hypokalemia—monitor in severe asthma or with diuretic use

Drug Interactions:

1. Beta-blockers: May antagonize salbutamol effect and induce bronchospasm
2. Diuretics, xanthines (theophylline): ↑ Risk of hypokalemia and arrhythmias
3. MAO inhibitors, tricyclic antidepressants: ↑ Cardiovascular effects
4. Always inform your doctor about all medications.

Additional Information:

1. Each inhaler contains 200 actuations
2. Store below 30°C; do not puncture or expose to heat
3. Rinse mouth after use to reduce throat irritation
4. Keep out of reach of children
5. Available over-the-counter or by prescription in Pakistan